TSC2 and neoplasm: In another study, treatment of A/J Tsc2+/- mice (9 months old) with 8 mg/kg of rapamycin weekly for 12 weeks, or daily for 4 weeks and weekly for another 8 weeks, had similar effects in reducing tumor burden (~80%) indicating that duration of treatment is more important than dose in eliciting a significant response (10).